Your browser doesn't support javascript.
loading
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Kumar, Shaji K; Callander, Natalie S; Adekola, Kehinde; Anderson, Larry D; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Castillo, Jorge J; Costello, Caitlin; D'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Garfall, Alfred; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Sborov, Douglas; Schroeder, Mark A; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Snedeker, Jenna; Kumar, Rashmi.
Affiliation
  • Kumar SK; Mayo Clinic Comprehensive Cancer Center.
  • Callander NS; University of Wisconsin Carbone Cancer Center.
  • Adekola K; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Anderson LD; UT Southwestern Simmons Comprehensive Cancer Center.
  • Baljevic M; Vanderbilt-Ingram Cancer Center.
  • Baz R; Moffitt Cancer Center.
  • Campagnaro E; University of Michigan Rogel Cancer Center.
  • Castillo JJ; Dana-Farber/Brigham and Women's Cancer Center.
  • Costello C; UC San Diego Moores Cancer Center.
  • D'Angelo C; Fred & Pamela Buffett Cancer Center.
  • Derman B; The UChicago Medicine Comprehensive Cancer Center.
  • Devarakonda S; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Elsedawy N; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
  • Garfall A; Abramson Cancer Center at the University of Pennsylvania.
  • Godby K; O'Neal Comprehensive Cancer Center at UAB.
  • Hillengass J; Roswell Park Comprehensive Cancer Center.
  • Holmberg L; Fred Hutchinson Cancer Center.
  • Htut M; City of Hope National Medical Center.
  • Huff CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Hultcrantz M; Memorial Sloan Kettering Cancer Center.
  • Kang Y; Duke Cancer Institute.
  • Larson S; UCLA Jonsson Comprehensive Cancer Center.
  • Lee H; The University of Texas MD Anderson Cancer Center.
  • Liedtke M; Stanford Cancer Institute.
  • Martin T; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Omel J; Patient Advocate.
  • Robinson T; Yale Cancer Center/Smilow Cancer Hospital.
  • Rosenberg A; UC Davis Comprehensive Cancer Center.
  • Sborov D; Huntsman Cancer Institute at the University of Utah.
  • Schroeder MA; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Sherbenou D; University of Colorado Cancer Center.
  • Suvannasankha A; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • Valent J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Varshavsky-Yanovsky AN; Fox Chase Cancer Center.
  • Snedeker J; National Comprehensive Cancer Network.
  • Kumar R; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 22(1D): e240001, 2024 01.
Article in En | MEDLINE | ID: mdl-38244272
ABSTRACT
The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, B-Cell / Waldenstrom Macroglobulinemia Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2024 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, B-Cell / Waldenstrom Macroglobulinemia Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2024 Type: Article